Federal Register / Vol. 75, No. 237 / Friday, December 10, 2010 / Notices 76993 

requirements of the applicable statutes 

and regulations. 

II. Comments 

Interested persons may submit to the 

Division of Dockets Management (see 

ADDRESSES) either electronic or written 

comments regarding this document. It is 

only necessary to send one set of 

comments. It is no longer necessary to 

send two copies of mailed comments. 

Identify comments with the docket 

number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

III. Electronic Access 

Persons with access to the Internet 

may obtain the guidance at http:// 

www.fda.gov/oc/advisory/default.htm. 

Dated: December 6, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–31022 Filed 12–9–10; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0001] 

Tobacco Products Scientific Advisory 

Committee; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: Tobacco Products 

Scientific Advisory Committee. 

General Function of the Committee: To 

provide advice and recommendations to the 

Agency on FDA’s regulatory issues. 

Date and Time: The meeting will be held 

on January 10 and 11, 2011 from 8 a.m. until 

5 p.m. 

Location: FDA White Oak Conference 

Center, Bldg. 31, rm. 1503, 10903 New 

Hampshire Ave., Silver Spring, MD 20993– 

0002. Information regarding special 

accommodations due to a disability, visitor 

parking and transportation may be accessed 

at: http://www.fda.gov/AdvisoryCommittees/ 

default.htm; under the heading ‘‘Resources 

for You,’’ click on ‘‘White Oak Conference 

Center Parking and Transportation 

Information for FDA Advisory Committee 

Meetings.’’ Please note that visitors to the 

White Oak Campus must have a valid 

driver’s license or other picture ID, and must 

enter through Building 1. 

Contact Person: Caryn Cohen, Office of 

Science, Center for Tobacco Products, Food 

and Drug Administration, 9200 Corporate 

Blvd., Rockville, MD 20850, 1–877–287–1373 

(choose Option 4), e-mail: 

TPSAC@fda.hhs.gov, or FDA Advisory 

Committee Information Line, 1–800–741– 

8138 (301–443–0572 in the Washington, DC 

area), code 8732110002. Please call the 

Information Line for up-to-date information 

on this meeting. A notice in the Federal 

Register about last minute modifications that 

impact a previously announced advisory 

committee meeting cannot always be 

published quickly enough to provide timely 

notice. Therefore, you should always check 

the Agency’s Web site and call the 

appropriate advisory committee hot line/ 

phone line to learn about possible 

modifications before coming to the meeting. 

Agenda: On January 10 and 11, 2011, the 

Committee will continue to (1) receive 

updates from the Menthol Report 

Subcommittee and (2) receive and discuss 

presentations regarding the data requested by 

the Committee at the March 30 and 31, 2010, 

meeting of the Tobacco Products Scientific 

Advisory Committee. 

FDA intends to make background material 

available to the public no later than 2 

business days before the meeting. If FDA is 

unable to post the background material on its 

Web site prior to the meeting, the background 

material will be made publicly available at 

the location of the advisory committee 

meeting, and the background material will be 

posted on FDA’s Web site after the meeting. 

Background material is available at http:// 

www.fda.gov/AdvisoryCommittees/Calendar/ 

default.htm. Scroll down to the appropriate 

advisory committee link. 

Procedure: Interested persons may present 

data, information, or views, orally or in 

writing, on issues pending before the 

committee. Written submissions may be 

made to the contact person on or before 

December 30, 2010. Oral presentations from 

the public will be scheduled between 

approximately 3 p.m. and 4 p.m. on January 

10, 2011. Those individuals interested in 

making formal oral presentations should 

notify the contact person and submit a brief 

statement of the general nature of the 

evidence or arguments they wish to present, 

the names and addresses of proposed 

participants, and an indication of the 

approximate time requested to make their 

presentation on or before December 21, 2010. 

Time allotted for each presentation may be 

limited. If the number of registrants 

requesting to speak is greater than can be 

reasonably accommodated during the 

scheduled open public hearing session, FDA 

may conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by December 22, 2010. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

Agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee meetings 

and will make every effort to accommodate 

persons with physical disabilities or special 

needs. If you require special accommodations 

due to a disability, please contact Caryn 

Cohen at least 7 days in advance of the 

meeting. 

FDA is committed to the orderly conduct 

of its advisory committee meetings. Please 

visit our Web site at http://www.fda.gov/ 

AdvisoryCommittees/ 

AboutAdvisoryCommittees/ucm111462.htm 

for procedures on public conduct during 

advisory committee meetings. 

Notice of this meeting is given under the 

Federal Advisory Committee Act (5 U.S.C. 

app. 2). 

Dated: December 3, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–31066 Filed 12–9–10; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 

Comment Request; Generic Clearance 

for Surveys of Customers and Partners 

of the Office of Extramural Research of 

the National Institutes of Health 

SUMMARY: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the Office of 

Extramural Research (OER), the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. This proposed 

information collection was previously 

published in the Federal Register on 

September 13, 2010 (Volume 75, 

Number 176, page 55585) and allowed 

60 days for public comment. One public 

comment was received. The purpose of 

this notice is to allow an additional 30 

days for public comment. The National 

Institutes of Health may not conduct or 

sponsor, and the respondent is not 

required to respond to, an information 

collection that has been extended, 

revised, or implemented on or after 

October 1, 1995, unless it displays a 

currently valid OMB control number. 

Proposed Collection: Title: Generic 

Clearance for Surveys of Customers and 

Partners of the Office of Extramural 

Research of the National Institutes of 

Health. Type of Information Collection 

Request: NEW. Need and Use of 

Information Collection: OER develops, 

coordinates the implementation of, and 

evaluates NIH-wide policies and 

procedures for the award of extramural 

funds . To move forward with our 

initiatives to ensure success in 

accomplishing the NIH mission, input 

from partners and customers is 

mstockstill on DSKH9S0YB1PROD with NOTICES

76994 Federal Register / Vol. 75, No. 237 / Friday, December 10, 2010 / Notices 

essential. Quality management 

principles have been integrated into 

OER’s culture and these surveys will 

provide customer satisfaction input on 

various elements of OER’s business 

processes. The approximately 14 (10 

quantitative and 4 qualitative) customer 

satisfaction surveys that will be 

conducted under this generic clearance 

will gather and measure customer and 

partner satisfaction with OER processes 

and operations. The data collected from 

these surveys will provide the feedback 

to track and gauge satisfaction with 

NIH’s statutorily mandated operations 

and processes. OER/OD/NIH will 

present data and outcomes from these 

surveys to inform the NIH staff, officers, 

leadership, advisory committees, and 

other decision-making bodies as 

appropriate. Based on feedback from 

these stakeholders, OER/OD/NIH will 

formulate improvement plans and take 

action when necessary. Frequency of 

Response: 1 response. Affected Public: 

Individuals. Type of Respondents: 

Science professionals (applicants, 

reviewers, Institutional Officials), adult 

science trainees, and the general public. 

The annual reporting burden is as 

follows: 

Quantitative surveys: 

Estimated Number of Respondents 

per Survey: 9,820; Estimated Number of 

Responses per Respondent: 1; Average 

Burden Hours per Response: 0.25; 

Estimated Total Annual Burden Hours 

Requested per Quantitative Survey: 

2,455; Estimated Total Annual Burden 

Hours Requested for 10 Quantitative 

Surveys: 24,550. 

Qualitative surveys: 

Estimated Number of Respondents 

per Survey: 30; Estimated Number of 

Responses per Respondent: 1; Average 

Burden Hours per Response: 1.0; 

Estimated Total Annual Burden Hours 

Requested per Qualitative Survey: 30; 

Estimated Total Annual Burden Hours 

Requested for 4 Qualitative Surveys: 

120. 

Based on an estimated 10 quantitative 

and 4 qualitative surveys per year: 

Estimated Total Combined Annual 

Hours of Burden Requested in Each of 

3 Years: 24,670. 

Estimated Total Combined Cost to 

Respondents: $728,326. 

Based on an estimated 10 quantitative 

and 4 qualitative surveys per year over 

3 years: 

Estimated Total Hours of Burden to 

Respondents for 2011, 2012, and 2013 

Combined: 74,010. 

Estimated Total Cost to Respondents 

for 2011, 2012, and 2013 Combined: 

$2,184,978. 

There are no Capital Costs to report. 

There are no Operating or Maintenance 

Costs to report. 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the function of the 

agency, including whether the 

information will have practical utility; 

(2) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information, including the validity of 

the methodology and assumptions used; 

(3) ways to enhance the quality, utility, 

and clarity of the information to be 

collected; and (4) ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974, Attention: Desk 

Officer for NIH. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and instruments, contact Dr. 

Gwynne L. Jenkins, Special Assistant to 

the Director, Office of Extramural 

Programs, OER, NIH, 6705 Rockledge 

Drive, Suite 350, Bethesda, MD 20892, 

or call non-toll-free number (301) 496– 

9232 or e-mail your request, including 

your address to: 

OEPMailbox@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30 days of the date of 

this publication. 

Dated: December 2, 2010. 

Sherry Mills, 

Director, Office of Extramural Programs. 

[FR Doc. 2010–31053 Filed 12–9–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: CASEKNOD Applications. 

Date: January 3, 2011. 

Time: 11 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Robert Weller, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3160, 

MSC 7770, Bethesda, MD 20892. (301) 435– 

0694. wellerr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Molecular Neuroscience. 

Date: January 4, 2011. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Carol Hamelink, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4192, 

MSC 7850, Bethesda, MD 20892. (301) 213– 

9887. hamelinc@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Pharmacology and Liver 

Pathobiology. 

Date: January 4, 2011. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Peter J. Perrin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2180, 

MSC 7818, Bethesda, MD 20892. (301) 435– 

0682. perrinp@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group Developmental Brain Disorders Study 

Section. 

Date: January 27–28, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marina del Rey Hotel, 13534 Bali 

Way, Marina del Rey, CA 90292. 

mstockstill on DSKH9S0YB1PROD with NOTICES